264 results on '"Li Houkai"'
Search Results
2. Zhi-Kang-Yin formula attenuates high-fat diet-induced metabolic disorders through modulating gut microbiota-bile acids axis in mice
3. Chrysanthemum morifolium Ramat extract and probiotics combination ameliorates metabolic disorders through regulating gut microbiota and PPARα subcellular localization
4. Gut microbiota-brain bile acid axis orchestrates aging-related neuroinflammation and behavior impairment in mice
5. Shexiang Baoxin Pill enriches Lactobacillus to regulate purine metabolism in patients with stable coronary artery disease
6. Efficacy and safety of Qushi Huayu, a traditional Chinese medicine, in patients with nonalcoholic fatty liver disease in a randomized controlled trial
7. Astragalus polysaccharides attenuate chemotherapy-induced immune injury by modulating gut microbiota and polyunsaturated fatty acid metabolism
8. Hyodeoxycholic acid ameliorates nonalcoholic fatty liver disease by inhibiting RAN-mediated PPARα nucleus-cytoplasm shuttling
9. Optimizing ex vivo culture conditions to study human gut microbiome
10. Activation of hepatic adenosine A1 receptor ameliorates MASH via inhibiting SREBPs maturation
11. Astragalus polysaccharide attenuates nonalcoholic fatty liver disease through THDCA in high-fat diet-fed mice
12. The identification of material basis of Si Miao Formula effective for attenuating non-alcoholic fatty liver disease
13. Gut microbiota remodeling improves natural aging-related disorders through Akkermansia muciniphila and its derived acetic acid
14. Different software processing affects the peak picking and metabolic pathway recognition of metabolomics data
15. A multiomics and network pharmacological study reveals the neuroprotective efficacy of Fu-Fang-Dan-Zhi tablets against glutamate-induced oxidative cell death
16. Serum proteomic analysis reveals the cardioprotective effects of Shexiang Baoxin Pill and Suxiao Jiuxin Pill in a rat model of acute myocardial infarction
17. Divergent impacts on the gut microbiome and host metabolism induced by traditional Chinese Medicine with Cold or Hot properties in mice
18. Functional Metabolomics Reveals that Astragalus Polysaccharides Improve Lipids Metabolism through Microbial Metabolite 2-Hydroxybutyric Acid in Obese Mice
19. A gulose moiety contributes to the belomycin (BLM) disaccharide selective targeting to lung cancer cells
20. Vancomycin pretreatment attenuates acetaminophen-induced liver injury through 2-hydroxybutyric acid
21. Exploring the mechanism underlying the cardioprotective effect of shexiang baoxin pill on acute myocardial infarction rats by comprehensive metabolomics
22. High Fat Diet and High Sucrose Intake Divergently Induce Dysregulation of Glucose Homeostasis through Distinct Gut Microbiota-Derived Bile Acid Metabolism in Mice
23. Exploring biological basis of Syndrome differentiation in coronary heart disease patients with two distinct Syndromes by integrated multi-omics and network pharmacology strategy
24. Astraglus polysaccharide attenuates nonalcoholic fatty liver disease through THDCA in high-fat diet-fed mice
25. Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota
26. Microbial-host-isozyme: a new territory for understanding personalized responses towards drug therapy
27. High Fat Diet and High Sucrose Intake Divergently Induce Dysregulation of Glucose Homeostasis through Distinct Gut Microbiota-Derived Bile Acid Metabolism in Mice.
28. Supporting Figure 4 from A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential
29. Supporting Table 2 from A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential
30. Supplementary Information from A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential
31. Supporting Table 1 from A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential
32. Supporting Figure 2 from A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential
33. Supporting Table 3 from A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential
34. Supporting Figure 3 from A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential
35. Supporting Figure 1 from A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential
36. Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism
37. The Microbial and Metabolic Signatures of Patients with Stable Coronary Artery Disease
38. Integrated microbiome and metabolome analysis reveals the potential therapeutic mechanism of Qing-Fei-Pai-Du decoction in mice with coronavirus-induced pneumonia
39. Microbial and Transcriptomic Profiling Reveals Diet-Related Alterations of Metabolism in Metabolic Disordered Mice
40. Effects of ATF4 on PGC1α expression in brown adipose tissue and metabolic responses to cold stress
41. Urinary Time- or Dose-Dependent Metabolic Biomarkers of Aristolochic Acid-Induced Nephrotoxicity in Rats
42. Integrated hepatic single-cell RNA sequencing and untargeted metabolomics reveals the immune and metabolic modulation of Qing-Fei-Pai-Du decoction in mice with coronavirus-induced pneumonia
43. Analysis of transcriptome and metabolome profiles alterations in fatty liver induced by high-fat diet in rat
44. A botanical dietary supplement from white peony and licorice attenuates nonalcoholic fatty liver disease by modulating gut microbiota and reducing inflammation
45. Integrated Metagenomic and Transcriptomic Analyses Reveal the Dietary Dependent Recovery of Host Metabolism From Antibiotic Exposure
46. Amygdala, an important regulator for food intake
47. ATF4 deficiency protects hepatocytes from oxidative stress via inhibiting CYP2E1 expression
48. Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota
49. Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice
50. Akkermansia muciniphila: is it the Holy Grail for ameliorating metabolic diseases?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.